12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several healthcare stocks experienced significant movements. Mira Pharmaceuticals, TC BioPharm, Panbela Therapeutics, Estrella Immunopharma, Bio-Path Holdings, and MyMD Pharmaceuticals were among the gainers, with increases ranging from 7.14% to 9.2%. Conversely, Impel Pharmaceuticals, Avenue Therapeutics, Cyclacel Pharmaceuticals, Alaunos Therapeutics, Evoke Pharma, and Scholar Rock Holding were the losers, with their stock prices falling between 7.07% and 20.9%.
November 24, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bio-Path Holdings' stock went up by 7.56% to $0.52, with a market cap of $6.4 million.
Bio-Path Holdings' after-market gain could lead to a short-term positive trend due to investor interest.
CONFIDENCE 80
IMPORTANCE 55
RELEVANCE 100
POSITIVE IMPACT
Estrella Immunopharma stock increased by 7.8% to $1.52, with a market cap of $53.5 million.
The positive movement in Estrella Immunopharma's stock suggests a bullish short-term sentiment among investors.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Mira Pharmaceuticals' stock rose by 9.2% to $3.59, with a market cap of $53.0 million.
The significant after-market gain for Mira Pharmaceuticals suggests positive investor sentiment which could lead to a short-term price increase.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
MyMD Pharmaceuticals' shares advanced by 7.14% to $0.33, with a market cap of $14.8 million.
The increase in MyMD Pharmaceuticals' stock price may suggest a short-term upward momentum due to market reactions.
CONFIDENCE 80
IMPORTANCE 55
RELEVANCE 100
POSITIVE IMPACT
Panbela Therapeutics' shares rose by 8.06% to $0.54, with a market cap of $2.7 million.
Panbela Therapeutics' stock price increase may continue into the short term, reflecting investor confidence.
CONFIDENCE 80
IMPORTANCE 55
RELEVANCE 100
POSITIVE IMPACT
TC BioPharm shares increased by 8.17% to $0.61, with a market cap of $5.7 million.
The after-market rise in TC BioPharm's stock price indicates a positive short-term outlook, potentially due to investor optimism.
CONFIDENCE 80
IMPORTANCE 55
RELEVANCE 100
NEGATIVE IMPACT
Avenue Therapeutics' shares fell by 18.57% to $0.15, with a market cap of $3.9 million.
Avenue Therapeutics' stock price decrease is likely to negatively impact investor sentiment in the short term.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Cyclacel Pharmaceuticals' stock declined by 11.8% to $0.27, with a market cap of $3.4 million.
The after-market decline for Cyclacel Pharmaceuticals may continue to affect the stock negatively in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Evoke Pharma's shares decreased by 10.16% to $1.15, with a market value of $3.8 million.
Evoke Pharma's stock price drop may reflect negative market sentiment, potentially leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Impel Pharmaceuticals' shares dropped by 20.9% to $0.67, with a market cap of $16.0 million.
The significant decline in Impel Pharmaceuticals' stock price could indicate a negative short-term outlook and potential selling pressure.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Scholar Rock Holding's stock decreased by 7.07% to $10.91, with a market cap of $787.0 million.
The decline in Scholar Rock Holding's stock price could lead to a negative short-term trend, as investor confidence may be shaken.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Alaunos Therapeutics' stock fell by 11.7% to $0.06, with a market value of $14.1 million.
The drop in Alaunos Therapeutics' stock price could suggest bearish investor sentiment and a negative short-term impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100